Flo-Tone MDI: inhaler training device

Clement Clarke has launched Flo-Tone MDI, a dual spacer and training device designed to encourage correct technique in patients using pressurised metered dose inhalers (pMDIs).

Flo-Tone MDI is suitable for patients from the age of 8 years
Flo-Tone MDI is suitable for patients from the age of 8 years

It can be used with Trainhaler or other placebo pMDI for training purposes under the supervision of a healthcare professional. The device gives an audible signal when the correct flow rate is achieved, helping to co-ordinate actuation of the aerosol canister and encouraging correct inhalation.

Flo-Tone MDI is available in regular (barrel-shaped) or circular formats to fit mouthpieces of all common pMDIs.

View Flo-Tone MDI drug record

Further information: Clement Clarke

Follow MIMS on Twitter

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

An elderly woman with one arm in a plaster cast sits resting both hands on her walker

Doctors urge NICE to reverse decision on new osteoporosis drug

More than NHS 100 clinicians have called on NICE to...

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Image of both strengths of Seffalair Spiromax inhaler side by side.

New salmeterol/fluticasone dry powder inhaler for asthma

Seffalair Spiromax is the sixth dry powder salmeterol/fluticasone...

An older man in a blue shirt and beige trousers leans forward on a sofa rubbing his painful lower back. Promoted
MIMSconnect

Established muscle relaxant offers new approach to managing back pain

Sponsored by Mibe Pharma

A muscle relaxant that has been used for decades outside the UK may provide an alternative to current treatments for low back pain, explains Dr Sunny Nayee, consultant in anaesthesia and pain medicine at Imperial College NHS Healthcare Trust.

Sponsored by Mibe Pharma UK Ltd. UK/MYO/21/044; December 2021.

Click here to view prescribing information for Myopridin® (pridinol mesilate)